Clinical Trial Update: HB-adMSCs for the Treatment of Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HB-adMSCs in Crohn's disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Crohn Disease (CD) | Phase 2 | Status: RECRUITING